2024 ACMT-EAPCCT Transatlantic Toxicology Talks Series | Utilizing Fomepizole in Acetaminophen Poisoning

Dr. Calello, a New Jersey native and devotee, is currently the Director of Medical Toxicology at Morristown Medical Center and a toxicologist at the New Jersey Poison Information and Education System (NJPIES). She has lectured and published on various facets of clinical toxicology, particularly as it pertains to extracorporeal treatment, intravenous lipid emulsion, and poisoning in the young child. Dr. Calello received her BA from the College of William and Mary and her MD from New Jersey Medical School. She completed residency training in pediatrics, and fellowship training in both pediatric emergency medicine and medical toxicology at the Children’s Hospital of Philadelphia and Poison Control Center in Philadelphia. Dr. Calello is board certified in pediatrics, pediatric emergency medicine, medical toxicology, and addiction medicine.

Dr. Kim Dalhoff received his MD from the University of Copenhagen in 1983. He is a specialist in hepatology and completed a clinical pharmacology degree in 2002.

Professor Dear trained in medicine at Oxford University and did a PhD in Pharmacology at University College London. Professor Dear spent 2 years at a research fellow at the National Institutes of Health, Bethesda, USA.   Since 2005, Professor Dear has been a Clinical Pharmacologist/Toxicologist at the Edinburgh University. In 2012, Professor Dear was awarded an NHS Research Scotland (NRS) Career Research Fellowship. In 2020 Professor Dear was made Professor of Clinical Pharmacology.

Dr. Hendrickson graduated from the State University of New York, Downstate College of Medicine, and completed training in Emergency Medicine and Medical Toxicology at the Medical College of Pennsylvania. He is a Professor of Emergency Medicine at Oregon Health and Sciences University where he is Chief of the Section of Medical Toxicology, Program Director for the fellowship in medical toxicology, and the Medical Director of the Oregon Poison Center.

Dr. Hantsch is a graduate of the Honors Program in Medical Education at Northwestern University. She completed an emergency medicine residency, including a year as chief resident, at the Medical College of Wisconsin and then continued her training in a medical toxicology fellowship at Vanderbilt University. After her fellowship, she spent nearly 22 years at Loyola University Chicago Stritch School of Medicine and Loyola University Medical Center. There, she established an inpatient toxicology clinical service and clinical rotations for graduate medical trainees and students in multiple fields. With an interest in medication management and safety, she joined the hospital Pharmacy and Therapeutics Committee, serving as member for 6 years before being appointed chair and leading the committee for another 6 years. Dr. Hantsch earned the academic rank of Professor of Emergency Medicine, was Director of the Division of Toxicology, and Director of Academic Affairs in the Department of Emergency Medicine. As a clinical faculty member, she was appointed to the Stritch Committee on Academic Rank and Tenure, serving for 7 years including 2 as a subcommittee chair leading revision of the clinician educator track guidelines. In 2018, she was the founding Program Director of the Loyola emergency medicine residency. Dr. Hantsch served for more than 8 years as Medical Director of the Illinois Poison Center. In addition, she is a regular organizer and contributor to many local, regional, and national/international continuing education programs. After leaving academics, she worked for the U.S. FDA in pharmacovigilance for a year. As of 2022, she is board certified in addiction medicine in addition to emergency medicine and medical toxicology. Dr. Hantsch was elected to the ACMT Board of Directors in 2021, is a member of the Education Committee, and chair of the Practice Committee.

Joshua D. King, MD, FACMT is an Associate Professor of Medicine and Pharmacy and the Medical Director of the Maryland Poison Center at the University of Maryland School of Medicine. He earned his medical degree from Penn State College of Medicine, followed by an Internal Medicine residency and chief residency at the University of Virginia. He then completed a Nephrology fellowship at Johns Hopkins Hospital and, after returning to the University of Virginia as a nephrologist, pursued further specialization through a Medical Toxicology fellowship. Dr. King is a dual-specialized clinician-educator in nephrology and medical toxicology, with clinical expertise in extracorporeal treatments for poisonings, therapeutic drug removal, ICU nephrology, and medical education. At the University of Maryland Medical Center, he provides care through both the nephrology and medical toxicology consultation services, focusing on hospitalized patients. In addition to his clinical work, Dr. King is deeply involved in graduate medical education, training residents and fellows, as well as teaching undergraduate medical students. As the Medical Director of the Maryland Poison Center, he oversees the clinical management of poisoning, envenomation, and overdose cases for both the public and healthcare providers. His role also includes educating medical and pharmacy students and supervising physicians who rotate through the center. Dr. King’s research interests lie at the intersection of nephrology and toxicology, particularly in the extracorporeal removal of toxins through modalities such as dialysis and apheresis.